Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Darlene J. Elias"'
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 2, Pp 217-223 (2020)
Abstract Background Serum amyloid A4 (SAA4) is an apolipoprotein that is in the SAA family and it is constitutively translated. Previously, acute‐phase SAA1 and SAA2 levels were associated with venous thromboembolism (VTE). Objective We investigate
Externí odkaz:
https://doaj.org/article/d7ed9394b3824e97868e63e756812a35
Autor:
Mohammed Hayat, Darlene J. Elias, Hiroshi Deguchi, John H. Griffin, Ali Torkamani, Meenal Shukla
Publikováno v:
Br J Haematol
Exomic rare variant polymorphisms (c. 300 000) were analysed in the Scripps Venous Thrombosis (VTE) registry (subjects aged
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 2, Pp 217-223 (2020)
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 2, Pp 217-223 (2020)
Background Serum amyloid A4 (SAA4) is an apolipoprotein that is in the SAA family and it is constitutively translated. Previously, acute‐phase SAA1 and SAA2 levels were associated with venous thromboembolism (VTE). Objective We investigated the ass
Autor:
Darlene J. Elias, Thomas J. Cramer, Laurent O. Mosnier, Annette von Drygalski, Andrew J. Gale, John H. Griffin, Vikas Bhat, Patricia M. Averell
Publikováno v:
Blood Adv
Control of bleeding with direct-acting oral anticoagulants (DOACs) remains an unmet clinical need. Activated superFactor V (superFVa) is an engineered activated protein C (APC)–resistant FVa variant with enhanced procoagulant activity resulting fro
Publikováno v:
Thromb Res
Background Purified skeletal muscle myosin (SkM) binds factor Xa and is procoagulant. The molecular forms of SkM in human plasma have not been characterized. Method Human plasma SkM heavy chain (HC) isoforms of different molecular weights were detect
Publikováno v:
Research and Practice in Thrombosis and Haemostasis. 1:93-102
Different minor abundance plasma lipids significantly influence thrombin generation in vitro and significant differences in such lipids are linked to risk for venous thrombosis. Some plasma sphingolipids including glucosylceramide, lyso-sulfatide and
Publikováno v:
Journal of Atherosclerosis and Thrombosis
Aim: Cholesteryl ester transfer protein (CETP) is an important lipid transfer factor in plasma that enhances prothrombinase activity in purified systems. This study was conducted to test the association of plasma CETP activity with venous thrombosis
Autor:
John H. Griffin, Silvia Navarro, Pilar Medina, Darlene J. Elias, Francisco España, Hiroshi Deguchi, W. Craig Hooper, Harland Austin, Nicole F. Dowling, Amanda B. Payne
Publikováno v:
Research And Practice In Thrombosis And Haemostasis
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Essentials Minor abundance plasma lipids, eg, glucosylceramide, can modulate blood coagulation reactions This lipid was measured in plasmas of 1 myocardial infarction and 2 venous thrombosis populations Low plasma glucosylceramide levels were found i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0953a3ea8f59a17360c28d1a058ce959
https://europepmc.org/articles/PMC5703432/
https://europepmc.org/articles/PMC5703432/
Autor:
Nicholas A. Kolaitis, Darlene J. Elias, Laurent O. Mosnier, Jill Waalen, Ming C Li, Matthew A. Allison, Doris Quon, Christina L. Wassel, Rebecca Kruse-Jarres, Ricki Bettencourt, Annette von Drygalski, Jaclyn Bergstrom
Publikováno v:
Hypertension. 62:209-215
Hypertension (HTN) is a major risk factor for intracranial hemorrhage. We, therefore, investigated the prevalence, treatment, and control of HTN in adult patients with hemophilia (PWH). PWH≥18 years (n=458) from 3 geographically different cohorts i
Autor:
Hiroshi Deguchi, John H. Griffin, Natalie M. Pecheniuk, Patricia M. Averell, Darlene J. Elias
Publikováno v:
Thrombosis and Haemostasis. 100:224-228
SummaryElevated plasma fibronectin levels occur in various clinical states including arterial disease. Increasing evidence suggests that atherothrombosis and venous thromboembolism (VTE) share common risk factors. To assess the hypothesis that high p